

(Alliance News) - Roquefort Therapeutics PLC on Monday was optimistic about its prospects for the new year, following a busy final quarter in 2022.


Roquefort Therapeutics PLC - London-based biotech company - Will present results from its anti-cancer RNA pre-clinical study on Tuesday afternoon at E...


(Alliance News) - Roquefort Therapeutics PLC on Friday reported a widened pretax loss but maintained a strong cash balance.


(Alliance News) - Roquefort Therapeutics PLC on Friday said it completed its acquisition of cancer-focused biotech firm Oncogeni Ltd for GBP5.5 millio...


Roquefort Therapeutics PLC - London-based biotechnology company - Says Midkine in vitro experiments completed with company's oligonucleotides reducing...


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: